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Background: People with a chronic illness are at increased risk for depression
and anxiety, however prevalence amongst people with CF and their care-givers is
unknown. This study aims to evaluate this, being the UK arm of the International
Depression & Anxiety Epidemiological Study (TIDES).
Methods: To date, 35 CF centres have been asked to participate. As of January
2010, 21 centres have agreed and are at varying stages of participation. Data is
collected from participants during regularly scheduled clinic visits, immediately
prior to consultation, who complete the HADS. Parent caregivers additionally
complete the CES-D questionnaire.
Results: Data has been collected and coded from 4 adult (N = 485), and 2 paediatric
centres (N = 233) (Total N = 718). We report preliminary data from 2 adult and
1 paediatric centres because they have reached the required epidemiological thresh-
old (70% of clinc). In adults, 29.6% reported some anxiety, 9.1% had varying levels
of depression. Of the children, 17.3% reported some anxiety but only 1 child was
depressed. In parent-caregivers, 48% reported anxiety and 20% depression using
the HADS. However, the CES-D score for the parent group indicated that 32.5%
had a clinically signiﬁcant level of depression.
Discussion: This early data from the ongoing, 3-year TIDES-UK study initially
suggests that anxiety and depression are indeed evident in CF groups. Recruitment
remains ongoing with the ultimate aim of securing participation of 35 UK CF
centres. We will present data exploring relationships between anxiety, depression
and demographic and clinical variables. The clinical implication of these ﬁndings
will be discussed.
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Introduction: Patients with chronic illness are at increased risk for depression and
anxiety, with serious consequences for health outcomes.
Objectives: To assess the prevalence of symptoms of depression and anxiety in
a sample of patients with cystic ﬁbrosis (CF) and its relation on the clinical
characteristics in two Spanish centres.
Methods: Cross sectional study. Administration of the Center of Epidemiological
Studies-Depression Scale (CES-D) and the Hospital Anxiety and Depression Scale
(HADS) to patients. Medical information, height and weight, lung function test
results and demographics data were collected.
Results: 79 adults with CF (45.6% male) completed the tests: mean age 25.9±7.7;
FEV1(%) 59.7±23.6%; BMI 21.7±3.3 kg/m2. 48% were employed, 5% were listed
for transplant. 92% were evaluated in routine visit. HADS score classiﬁed 24%
of the patients with anxiety or borderline symptoms and 13.9 % with depression
or borderline. The CESD score classiﬁed 51% of the patients with depression.
Female patients had signiﬁcantly more prevalence of depression by CESD than
male. Patients with severe disease (FEV1%< 40) had signiﬁcantly worse HADS-
Anxiety score than mild or normal. FEV1% had signiﬁcantly negative corrrelation
with HADS-Anxiety and CESD scores.
Conclusions: The presence of symptoms of depression and anxiety were high in
adults with CF; higher in females and with severe disease, and similar than other
results reported previously. The proportion of patients with a positive screening for
depression assessed by CESD test was higher than the one assessed by HADS,
probably due to the inclusion of somatics items.
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Background: Although there is a higher risk of depression and anxiety in chronic
illness, prevalence and associated suicidal ideation are relatively unexplored in
CF. This study was the UK pilot for the International Depression and Anxiety
Epidemiological Study (TIDES-UK) in a single major CF centre.
Method: Questionnaires gathering demographic and medical information and two
mental health screening instruments, the Patient Health Questionnaire for depression
(PHQ9) and the Hospital Anxiety and Depression Scale (HADS) were administered
to adults with CF attending the RACFU, Leeds, before routine out-patient appoint-
ments.
Results: 233 patients took part (mean age 27 yrs; 57% male; mean FEV1 61.8%
predicted (sd 22.5). PHQ9 data showed 49 (21%) with mild and 30 (12.9%) with
moderate/severe depression, with 25 (10.8%), endorsing the suicidal ideation ‘risk’
item. HADS-D data showed 12 (5.2%) with mild and 1 moderate depression
(0.4%). HADS-A data showed 38 (16.4%) with mild and 18 moderate/severe
anxiety (7.7%). There were signiﬁcant negative correlations between FEV1 PP
and HADS depression (Spearman’s rho = −0.264; P = 0.000, n = 198) and PHQ9
depression (Spearman’s rho = −0.152; P = 0.033, n = 199), but no relationship with
anxiety.
Discussion: This study found higher rates of depression on the PHQ9 than HADS
and signiﬁcant associations between lung function and depression on both measures.
Suicidal ideation appears more frequent than reported in other populations [1]. We
previously suggested that some CF carers ﬁnd responding to this difﬁcult [2] and
discuss clinical implications.
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Purpose: Having a child with a chronic disease may cause anxiety and depression
and impair sleep quality of mothers. The aim of this study was to compare sleep
quality, anxiety and depression in mothers of in and outpatients with cystic ﬁbrosis.
Materials and Methods: The study included mothers of 28 children with cystic
ﬁbrosis. 12 of them were hospitalized (6 male, 6 female; mean age 7.83±3.06 years)
and 16 of them were outpatients (9 male, 7 female; mean age 7.81±3.79 years).
The parents were asked to mark fatigue level, sleep disturbances, stress level and
the severity of disease of their child on a visual analog scale (VAS). Pittsburgh
Sleep Quality Index (PSQI) and Hospital Anxiety and Depression Scale (HADS)
were administered to mothers.
Results: Sleep disturbance, fatigue, anxiety and depression levels of inpatients’
mothers were higher than outpatients’ mothers (p< 0.05). PSQI subscores and total
scores were higher than in inpatient mothers (p< 0.05). HADS scores were lower
than in outpatients’ mothers (p< 0.05).
Conclusion: We concluded that chronic illness may impact the sleep of the
family members especially during hospitalization. Therefore cystic ﬁbrosis patients’
mothers should be assessed from the view point of sleep quality, fatigue level,
anxiety and depression.
